---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-049748"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T00:41:10.800317+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CFO Ronald McClurg to retire June 30, 2026; COO Christopher Volker to succeed as CFO

## Summary
- Ronald McClurg to retire as CFO effective June 30, 2026, then serve as Senior Advisor until Dec 31, 2026.
- Christopher Volker, current COO, appointed CFO effective July 1, 2026; base salary increased to $350,000.
- Volker brings medtech experience from Abbott, CSI, St. Jude Medical; holds Wharton MBA and CFA.
- McClurg entered Transition and Release Agreement dated April 28, 2026; will receive salary/benefits through retirement and provide general release.
- McClurg's equity awards (options/RSUs) continue per plan terms; no immediate change to equity.

## SEC filing metadata
- accession: 0001213900-26-049748
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390026049748/0001213900-26-049748-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390026049748/ea0288229-8k_neuroone.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-049748
- JSON: https://secwatch.observer/filing/0001213900-26-049748.json
- Plain text: https://secwatch.observer/filing/0001213900-26-049748.txt

## Key facts
- Executive change
  Christopher Volker was appointed as Chief Financial Officer at NEUROONE MEDICAL TECHNOLOGIES Corp.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: the Board announced that Christopher Volker, the Company’s Chief Operating Officer, will succeed Mr. McClurg as the Company’s Chief Financial Officer effective as of July 1, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1500198/000121390026049748/0001213900-26-049748-index.htm
- Executive change
  Ronald McClurg departed as Chief Financial Officer at NEUROONE MEDICAL TECHNOLOGIES Corp.
  - Action: retire
  - Role: Chief Financial Officer
  source text: On April 24, 2026, Ronald McClurg notified NeuroOne Medical Technologies Corporation (the "Company") of his intention to retire as the Company’s Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1500198/000121390026049748/0001213900-26-049748-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.